Search Browse Earnings

2seventy bio, Inc. — SlamSEC

2seventy bio, Inc.

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$100.4M

+84.1% YoY

FY 2024

Adj. EBITDA

-$227.3M

-226.4% margin

FY 2024

Net Income

-$217.6M

-216.7% margin

FY 2024

EPS (Diluted)

-$4.42

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$75.0M

FY 2024

Total Debt

—

Net Cash

$75.0M

FY 2024

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

—

Employees

—